Home > Insider Trading > Filing (0001127602-14-006176)

Filing Details

Accession Number:: 0001127602-14-006176
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-13 17:59:53
Reporting Period:: 2014-02-11

Filing Date:: 2014-02-13
Accepted Time:: 2014-02-13 17:59:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1214127	Jr J Louis Lavigne	2525 Dupont Drive Irvine CA 92612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-11	11,400	$54.32	24,123	No	4	M	Direct
Common Stock	Disposition	2014-02-11	11,400	$122.41	12,723	No	4	S	Direct
Common Stock	Acquisiton	2014-02-11	11,400	$46.66	24,123	No	4	M	Direct
Common Stock	Disposition	2014-02-11	11,400	$122.41	12,723	No	4	S	Direct
Common Stock	Acquisiton	2014-02-11	11,400	$61.98	24,123	No	4	M	Direct
Common Stock	Disposition	2014-02-11	11,400	$122.40	12,723	No	4	S	Direct
Common Stock	Acquisiton	2014-02-11	9,000	$51.72	21,723	No	4	M	Direct
Common Stock	Disposition	2014-02-11	9,000	$122.40	12,723	No	4	S	Direct
Common Stock	Acquisiton	2014-02-11	11,400	$60.60	24,123	No	4	M	Direct
Common Stock	Disposition	2014-02-11	11,400	$122.35	12,723	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2014-02-11	11,400	$0.00	11,400	$54.32
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2014-02-11	11,400	$0.00	11,400	$46.66
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2014-02-11	11,400	$0.00	11,400	$61.98
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2014-02-11	9,000	$0.00	9,000	$51.71
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2014-02-11	11,400	$0.00	11,400	$60.60

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	2018-05-06	No	4	M	Direct
	2019-04-30	No	4	M	Direct
	2020-04-29	No	4	M	Direct
2007-05-02	2016-05-02	No	4	M	Direct
	2017-05-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,800	Indirect	By Lavigne Survivor's Trust
Common Stock	5,400	Indirect	By Rachel Lavigne Exmpt Bypass Trust
Common Stock	0	Indirect	By Lavigne Family Trust

Footnotes

The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $122.40 to $122.457, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $122.40 to $122.54, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $122.37 to $122.43, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $122.32 to $122.494, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
Shares held by the Louis Lavigne Survivor's Trust. Reporting Person is sole trustee of the Louis Lavigne Survivor's Trust.
Shares held by the Rachel Lavigne Exmpt Bypass Trust. Reporting Person is sole trustee of the Rachel Lavigne Exmpt Bypass Trust.
Shares held by the Lavigne Family Trust. Reporting Person is trustee of the Lavigne Family Trust.
The per share exercise price is the closing price of Allergan's common stock as of the date of grant.
Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.